MEK inhibitor Refametinib, Purity ≥98%

Cat. No.: X23-10-ZQ832

MEK inhibitor Refametinib, Purity ≥98%

Synonym: Refametinib (R enantiomer); 923032-38-6; RDEA119 R enantiomer; Refametinib R enantiomer; N-[3,4-Difluoro-2-(2-fluoro-4-iodoanilino)-6-methoxyphenyl]-1-[(2R)-2,3-dihydroxypropyl]cyclopropane-1-sulfonamide; MEK inhibitor

  • CAS Number: 923032-38-6
  • Compound CID: 50912933
Product Size
10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Refametinib prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
Molecular Weight
572.34
Molecular Formula
C19H20F3IN2O5S
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Refametinib can be used to study the inhibition of MEK1/2 in cancer models and its potential therapeutic applications.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0